KLSE (MYR): KOTRA (0002)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
4.80
Today's Change
+0.04 (0.84%)
Day's Change
4.70 - 4.80
Trading Volume
50,000
Market Cap
712 Million
NOSH
148 Million
Latest Quarter
31-Dec-2023 [#2]
Announcement Date
21-Feb-2024
Next Quarter
31-Mar-2024
Est. Ann. Date
26-May-2024
Est. Ann. Due Date
30-May-2024
QoQ | YoY
-14.96% | -29.22%
Revenue | NP to SH
226,051.000 | 55,859.000
RPS | P/RPS
152.41 Cent | 3.15
EPS | P/E | EY
37.66 Cent | 12.74 | 7.85%
DPS | DY | Payout %
27.97 Cent | 5.83% | 74.25%
NAPS | P/NAPS
1.85 | 2.59
QoQ | YoY
-7.91% | -17.76%
NP Margin | ROE
24.71% | 20.36%
F.Y. | Ann. Date
31-Dec-2023 | 21-Feb-2024
Latest Audited Result
30-Jun-2023
Announcement Date
27-Oct-2023
Next Audited Result
30-Jun-2024
Est. Ann. Date
27-Oct-2024
Est. Ann. Due Date
27-Dec-2024
Revenue | NP to SH
242,199.000 | 65,234.000
RPS | P/RPS
163.30 Cent | 2.94
EPS | P/E | EY
43.98 Cent | 10.91 | 9.16%
DPS | DY | Payout %
25.45 Cent | 5.30% | 57.85%
NAPS | P/NAPS
1.83 | 2.63
YoY
5.06%
NP Margin | ROE
26.93% | 24.09%
F.Y. | Ann. Date
30-Jun-2023 | 23-Aug-2023
Revenue | NP to SH
221,710.000 | 50,552.000
RPS | P/RPS
149.49 Cent | 3.21
EPS | P/E | EY
34.08 Cent | 14.08 | 7.10%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
-7.48% | -27.06%
NP Margin | ROE
22.80% | 18.43%
F.Y. | Ann. Date
31-Dec-2023 | 21-Feb-2024
Trailing 4 Quarters | Trailing 8 Quarters | |||
---|---|---|---|---|
Available Quarters | 4 Quarters | 8 Quarters | ||
Continuous Quarters Of Revenue Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
Total Positive Profit Years | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
Continuous Quarters Of Positive Profit | 4 / 4 | 100.00% | 8 / 8 | 100.00% |
Continuous Quarters Of Profit Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Adjusted EPS Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Total Dividend Years | 2 / 4 | 50.00% | 3 / 8 | 38.00% |
Continuous Quarters Of Dividend | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
Continuous Quarters Of Dividend Growth | 0 / 4 | 0.00% | 0 / 8 | 0.00% |
Continuous Quarters Of Adjusted Dps Growth | 1 / 4 | 25.00% | 1 / 8 | 12.50% |
Average ROE | 5.15% | 6.02% | ||
Average Net Profit Margin | 24.68% | 27.17% |
Last 5 Financial Years | Last 10 Financial Years | |||
---|---|---|---|---|
Available Years | 5 Years | 10 Years | ||
Continuous Quarters Of Revenue Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Total Positive Profit Years | 5 / 5 | 100.00% | 10 / 10 | 100.00% |
Continuous Quarters Of Positive Profit | 5 / 5 | 100.00% | 10 / 10 | 100.00% |
Continuous Quarters Of Profit Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Continuous Quarters Of Adjusted EPS Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Total Dividend Years | 5 / 5 | 100.00% | 7 / 10 | 70.00% |
Continuous Quarters Of Dividend | 5 / 5 | 100.00% | 7 / 10 | 70.00% |
Continuous Quarters Of Dividend Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Continuous Quarters Of Adjusted Dps Growth | 2 / 5 | 40.00% | 2 / 10 | 20.00% |
Average ROE | 18.04% | 12.08% | ||
Average Net Profit Margin | 20.43% | 12.78% |
T4Q | Annualized | Annual (Unaudited) | Last 10 FY Average | Last 5 FY Average | |
---|---|---|---|---|---|
Revenue | 226,051 | 221,710 | 242,199 | 175,163 | 190,803 |
NP to SH | 55,859 | 50,552 | 65,234 | 24,609 | 40,694 |
Dividend | 41,477 | 37,074 | 37,740 | 7,075 | 13,088 |
Adjusted EPS | 37.66 | 34.08 | 43.98 | 16.59 | 27.44 |
Adjusted DPS | 27.97 | 25.00 | 25.45 | 4.77 | 8.82 |
NP to SH = Net Profit Attributable to Shareholder, EPS = Earning Per Share, DPS = Dividend Per Share
All figures in '000 unless specified.
EPS & DPS's figures in Cent.
LQ QoQ | LQ YoY | CQ YoY | LQ vs Average of T4Q | LQ vs Average of T8Q | |
---|---|---|---|---|---|
Revenue | 7.95% | -7.56% | -12.71% | 1.83% | 0.72% |
NP to Owner | -14.96% | -29.22% | -27.06% | -16.82% | -24.93% |
Dividend | 0.00% | 25.26% | 25.26% | 78.77% | 163.52% |
Adjusted EPS | -14.96% | -29.22% | -27.06% | -16.82% | -24.93% |
Adjusted DPS | 0.00% | 25.26% | 25.26% | 78.77% | 163.52% |
LQ = Latest Quarter, CQ = Cumulative Quarter, T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, QoQ = Quarter on Quarter, YoY = Year on Year
T4Q vs LFY | T4Q vs AL5FY | T4Q vs AL10FY | AQR vs LFY | AQR vs AL5FY | AQR vs AL10FY | LFY YoY | LFY vs AL5FY | LFY vs AL10FY | |
---|---|---|---|---|---|---|---|---|---|
Revenue | -6.67% | 18.47% | 29.05% | -8.46% | 16.20% | 26.57% | 16.49% | 26.94% | 38.27% |
NP to Owner | -14.37% | 37.27% | 126.98% | -22.51% | 24.22% | 105.41% | 5.06% | 60.30% | 165.07% |
Dividend | 9.90% | 216.90% | 486.21% | -1.77% | 183.26% | 423.97% | 168.47% | 188.35% | 433.39% |
Adjusted EPS | -14.37% | 37.27% | 126.98% | -22.51% | 24.22% | 105.41% | 5.06% | 60.30% | 165.07% |
Adjusted DPS | 9.90% | 216.90% | 486.21% | -1.77% | 183.26% | 423.97% | 168.47% | 188.35% | 433.39% |
T4Q = Trailing 4 Quarters, T8Q = Trailing 8 Quarters, AL5FY = Average of Last 5 Financial Years, AL10FY = Average of Last 10 Financial Years, LFY = Latest Financial Year AQR = Annualized Quarter Result, YoY = Year on Year
After one year and a half, Kotra Industries has finally reached its true intrinsic value.
Take profit 30%
2022-12-12 17:04
Downgrade Kotra Industries to Neutral from Overweight (Short term), Long-term is still overweight
2022-12-12 17:05
Healthcare stocks perform well at the end of an economic cycle. Right before the beginning of a global recession, healthcare stock will most likely peak, followed by a S/T correction. We are currently in the final stage of growth, soon to enter Stage 1 of recession. Earliest is between Q1 and Q2 2023
2022-12-12 17:08
Final price target is RM7.80 by the end of Q1 2023
Slowly take profit as the stock goes up 20%
2022-12-12 17:11
pang72 when are you going to bring your wife to Europe for holiday?
2022-12-14 09:29
pang72, Kotra management almost wants to cash out already. In times of crisis like this, it is better to sell and take profit
2022-12-18 21:22
Kotra is a downgrade from Overweight to Equal-weight, still a Hold but no longer trading at attractive valuation
2022-12-18 21:23
Kotra will reach blue chip status by 2025, but short term trader will want to exit the stock by year-end
2022-12-18 21:30
Integrity. Intelligent. Industrious. 3iii (iiinvestsmart)$â¬Â£Â¥
Security LastPr PE DY% Divcts ROE ttm-marg
KOTRA (Pharmaceuticals) 5.6 12.2 4.6 25.5 26.68 29.4
2023-03-30 16:09
Final QR expected to be very good. Also final dividends, expect to be superb. ESOS 202k @ 4.99, ur guess. Leaps & bounds, the results.
2023-07-27 20:42
15.5 cents dividend, read it properly, it’s not final dividend. There’s another final dividend coming soon
2023-08-24 19:04
Previous preceding Quarter, the 0.16 was declared as final dividend but this 0.155 was declared as 2nd interim. So very high chance there’s another final
2023-08-25 14:02
If there’s final dividend, probably after the X of the 0155 cents. Probably November
2023-08-31 12:24
I just bought 5.21 and now dropped to 5.13 suddenly? What they're playing?
2023-10-04 10:25
Look at its issued capital and its profit, probably can declare bonus issues..
very quiet here.
pp said go to quiet place is safer..
what is your opinion?
2024-01-19 11:55
wallstreetrookie
Love Kotra. Keep adding on weakness
2022-11-10 14:53